PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97268224 |
Filing Date: 02/15/2022 |
Input Field |
Entered |
TEAS Plus | YES |
---|---|
MARK INFORMATION | |
*MARK | SLINGSHOT |
*STANDARD CHARACTERS | YES |
USPTO-GENERATED IMAGE | YES |
LITERAL ELEMENT | SLINGSHOT |
*MARK STATEMENT | The mark consists of standard characters, without claim to any particular font style, size, or color. |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | Slingshot Biosciences, Inc. |
DBA/AKA/TA/FORMERLY | AKA Slingshot Bio |
INTERNAL ADDRESS | Suite 330 |
*MAILING ADDRESS | 1250 45th Street, Suite 330 |
*CITY | Emeryville |
*STATE (Required for U.S. applicants) |
California |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
94608 |
PHONE | 510-770-6806 |
*EMAIL ADDRESS | XXXX |
WEBSITE ADDRESS | slingshotbio.com |
LEGAL ENTITY INFORMATION | |
*TYPE | CORPORATION |
* STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION | Delaware |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
*INTERNATIONAL CLASS | 001 |
*IDENTIFICATION | Assays and reagents for use in genetic research; Biochemical reagents used for non-medical purposes; Chemical reagents for non-medical purposes; Chemicals for use in biotechnological product development; Diagnostic preparations for clinical or medical laboratory use; Reagents for research purposes; Reagents for scientific or medical research use; Reagents for use in scientific apparatus for chemical or biological analysis |
*FILING BASIS | SECTION 1(a) |
FIRST USE ANYWHERE DATE | At least as early as 02/14/2012 |
FIRST USE IN COMMERCE DATE | At least as early as 02/14/2012 |
SPECIMEN FILE NAME(S) | |
ORIGINAL PDF FILE | SPE0-767718058-2022021516 2311420026_._FlowCytes___ Slingshot_Bio.pdf |
CONVERTED PDF FILE(S) (5 pages) |
\\TICRS\EXPORT18\IMAGEOUT 18\972\682\97268224\xml1\ FTK0003.JPG |
\\TICRS\EXPORT18\IMAGEOUT 18\972\682\97268224\xml1\ FTK0004.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\972\682\97268224\xml1\ FTK0005.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\972\682\97268224\xml1\ FTK0006.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\972\682\97268224\xml1\ FTK0007.JPG | |
SPECIMEN DESCRIPTION | Webpage showing mark affixed to goods |
WEBPAGE URL | http://shop.slingshotbio.com/collections/flowcytes |
WEBPAGE DATE OF ACCESS | 02/15/2022 |
*INTERNATIONAL CLASS | 005 |
*IDENTIFICATION | Diagnostic biomarker reagents for medical purposes; Diagnostic reagents for medical use; Medical diagnostic reagents for the analysis of body fluids |
*FILING BASIS | SECTION 1(a) |
FIRST USE ANYWHERE DATE | At least as early as 02/14/2012 |
FIRST USE IN COMMERCE DATE | At least as early as 02/14/2012 |
SPECIMEN FILE NAME(S) | |
ORIGINAL PDF FILE | SPE0-767718058-2022021516 2311420026_._TruCytes___S lingshot_Bio.pdf |
CONVERTED PDF FILE(S) (10 pages) |
\\TICRS\EXPORT18\IMAGEOUT 18\972\682\97268224\xml1\ FTK0008.JPG |
\\TICRS\EXPORT18\IMAGEOUT 18\972\682\97268224\xml1\ FTK0009.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\972\682\97268224\xml1\ FTK0010.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\972\682\97268224\xml1\ FTK0011.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\972\682\97268224\xml1\ FTK0012.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\972\682\97268224\xml1\ FTK0013.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\972\682\97268224\xml1\ FTK0014.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\972\682\97268224\xml1\ FTK0015.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\972\682\97268224\xml1\ FTK0016.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\972\682\97268224\xml1\ FTK0017.JPG | |
SPECIMEN DESCRIPTION | Webpage showing mark affixed to goods |
WEBPAGE URL | http://shop.slingshotbio.com/collections/trucell-trucytes |
WEBPAGE DATE OF ACCESS | 02/15/2022 |
ADDITIONAL STATEMENTS INFORMATION | |
*TRANSLATION (if applicable) |
|
*TRANSLITERATION (if applicable) |
|
*CLAIMED PRIOR REGISTRATION (if applicable) |
|
*CONSENT (NAME/LIKENESS) (if applicable) |
|
*CONCURRENT USE CLAIM (if applicable) |
|
CORRESPONDENCE INFORMATION | |
NAME | Slingshot Biosciences, Inc. |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | allan@slingshotio.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | jeff@slingshotbio.com |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Plus |
NUMBER OF CLASSES | 2 |
APPLICATION FOR REGISTRATION PER CLASS | 250 |
*TOTAL FEES DUE | 500 |
*TOTAL FEES PAID | 500 |
SIGNATURE INFORMATION | |
* SIGNATURE | /Allan Kiang/ |
* SIGNATORY'S NAME | Allan Kiang |
* SIGNATORY'S POSITION | General Counsel |
SIGNATORY'S PHONE NUMBER | 925-353-6427 |
* DATE SIGNED | 02/15/2022 |
SIGNATURE METHOD | Signed directly within the form |
PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97268224 |
Filing Date: 02/15/2022 |
The applicant's current Correspondence Information: |
Slingshot Biosciences, Inc. |
PRIMARY EMAIL FOR CORRESPONDENCE: allan@slingshotio.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): jeff@slingshotbio.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|